SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-178571
Filing Date
2023-06-29
Accepted
2023-06-29 16:03:49
Documents
5
Period of Report
2023-06-29

Document Format Files

Seq Description Document Type Size
1 6-K d524659d6k.htm 6-K 20564
2 EX-99.1 d524659dex991.htm EX-99.1 67193
3 GRAPHIC g524659dsp5.jpg GRAPHIC 3428
4 GRAPHIC g524659dsp6.jpg GRAPHIC 2572
5 GRAPHIC g524659dsp7.jpg GRAPHIC 2705
  Complete submission text file 0001193125-23-178571.txt   101279
Mailing Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW 44 (0)20 8154 4600
Achilles Therapeutics plc (Filer) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40299 | Film No.: 231057359
SIC: 2836 Biological Products, (No Diagnostic Substances)